Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027066 (
myoclonus
)
4,275
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Dentatorubropallidoluysian atrophy
is a neurodegenerative disorder with characteristic pathology, chiefly described in reports from Japan, and is associated with an unstable CAG trinucleotide repeat in a gene on chromosome 12. We describe four European families, three British and one Maltese, with this mutation. All exhibited autosomal dominant inheritance, and there was evidence for anticipation associated with an increase of the expansion with paternal transmission in two families. Affected chromosomes from patients with dentatorubropallidoluysian atrophy had CAG expansions of 58 to 74 repeats, compared to 7 to 26 in control chromosomes, and the size of repeat was significantly inversely correlated with age of onset. The clinical features were diverse, even within individual families, and comprised a combination of a movement disorder (chorea,
myoclonus
, dystonia, or parkinsonism), cerebellar ataxia, epilepsy, psychosis, and dementia. A clinical diagnosis of Huntington's disease had been made in affected individuals from all families. Neuropathological examination of 2 patients showed no specific abnormality in one and degenerative changes predominantly affecting the spinal cord in the other. Investigation of 55 patients who might represent sporadic examples of dentatorubropallidoluysian atrophy did not detect any expanded alleles.
Dentatorubropallidoluysian atrophy
is likely to be more common than previously recognized in non-Japanese populations, and should be considered in any patient with a dominantly inherited neurodegenerative disorder with the above-mentioned clinical features.
...
PMID:A clinical and molecular genetic study of dentatorubropallidoluysian atrophy in four European families. 771 81
Dentatorubropallidoluysian atrophy
(
DRPLA
) is an autosomal dominant neurodegenerative disorder characterized by a variable combination of progressive ataxia, epilepsy,
myoclonus
, choreoathetosis and dementia. This disease is caused by a (CAG)(n) expansion in the
DRPLA
gene, on chromosome 12p13.
DRPLA
is prevalent in Japan, but several families of non-Japanese ancestry have already been published. To identify the origin of expanded alleles in Portuguese families with
DRPLA
, we studied two previously reported intragenic SNPs in introns 1 and 3, in addition to the CAG repeat of the
DRPLA
gene. The results showed that all four Portuguese
DRPLA
families shared the same haplotype, which is also common to that reported for Japanese
DRPLA
chromosomes. This haplotype is also the most frequent in Japanese normal alleles, whereas it was rare in Portuguese control chromosomes. Thus, our findings support that a founder
DRPLA
haplotype of Asian origin was introduced in Portugal, being responsible for the frequency of the disease in this country.
...
PMID:Portuguese families with dentatorubropallidoluysian atrophy (DRPLA) share a common haplotype of Asian origin. 1451 72